Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failure
- 31 January 1985
- journal article
- clinical trial
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 5 (1), 101-107
- https://doi.org/10.1016/s0735-1097(85)80090-5
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- A placebo-controlled trial of captopril in refractory chronic congestive heart failureJournal of the American College of Cardiology, 1983
- CaptoprilDrugs, 1983
- Safety and Efficacy of Chronic Therapy with Captopril in Hypertensive Patients: An UpdateThe Journal of Clinical Pharmacology, 1981
- ANTIHYPERTENSIVE EFFECT OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME INHIBITOR "MK-421".The Lancet, 1981
- A new class of angiotensin-converting enzyme inhibitorsNature, 1980
- Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure.Circulation, 1980
- Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.Circulation, 1980
- Adverse Effects of D-Penicillamine in Rheumatoid ArthritisAnnals of Internal Medicine, 1980
- Angiotensin converting enzyme inhibition in patients with congestive heart failure.Circulation, 1978
- Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure.Circulation, 1978